News

These new data are from an open label follow-up extension of patients originally enrolled in the TEMPO trial, a 12-month study conducted in 32 centers in the US

Abilify (aripiprazole) tablets and oral solution have been approved for maintaining efficacy in patients with bipolar I disorder with a recent manic or mixed episode, who had been

New data has shown that Imvamune is expected to be effective in protecting against smallpox infection three days after just one vaccination compared to traditional vaccines, such as

Specifically, the study used Bayer Aspirin and showed a 17% reduction in the risk of a first stroke, and a 24% reduction in the risk of an ischemic

By the end of an eight-week study, patients treated with Cymbalta (duloxetine hydrochloride) 60mg once daily demonstrated significantly greater improvement in cognition when compared to those treated with

Under the agreement, Johnson & Johnson Pharmaceutical R&D (J&JPRD) will use proprietary pathway inference technology and data-driven computer models from Gene Network Sciences (GNS) to help determine the

However, although the study of Xyotax in combination with carboplatin in non-small cell lung cancer (NSCLC), known as STELLAR 3, missed its primary endpoint, it did meet statistical

According to the results, styrylquinolines (SQLs) are synergistic with reverse transcriptase inhibitors, namely zidovudine (GlaxoSmithKline’s Retrovir) and nevirapine (Boehringer Ingelheim’s Viramune), and with another family of integrase inhibitors,

In the phase I/II clinical trial, patients received MDX-010 every three weeks, plus high dose IL-2 therapy. Study results show that eight of 36 patients with metastatic melanoma